Z. A. Alobaidi and S. I. Mohammed, “Association of Disease Duration and Duration of Olanzapine Use with Blood Sugar, Blood Pressure, BMI, and Lipid Profile among Schizophrenic Patients in Iraq”, Al-Rafidain J Med Sci, vol. 4, pp. 79–85, Jun. 2023.